NMRA Neumora Therapeutics, Inc. - Common Stock
$1.72
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$1–$4
36% of range
Analyst Rating
BUY
15 analysts
Price Target
$9
+418% upside
P/E (TTM)
-1.2
ROE
-165.2%
Net Profit Margin
—
NMRA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.72
Market Cap
$312M
P/E (TTM)
-1.2
EPS (TTM)
$-1.45
Revenue (TTM)
—
Div Yield
—
ROE
-165.2%
Debt/Equity
1.1
52W Range
$1 – $4
NMRA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-1.45
2022-12-31
→
2025-12-31
Free Cash Flow
—
2023-12-31
→
2023-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NMRA
Peer Median
P/E (TTM)
-1.2
24.0
P/B
3.0
2.0
EV / EBITDA
-1.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NMRA
Peer Median
ROA
-93.3%
-22.8%
ROE
-165.2%
-24.5%
ROIC
-110.5%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NMRA
Peer Median
Debt / Equity
1.1
0.0
Current Ratio
5.9
7.8
Quick Ratio
5.6
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NMRA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NMRA
Peer Median
NMRA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
15 analysts
- Strong Buy 5 33.3%
- Buy 7 46.7%
- Hold 2 13.3%
- Sell 1 6.7%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-05-16
Median
$7.63
Mean
$8.91
← Below all targets
$1.72
Low
$3.00
High
$18.00
Median target
$7.63
+343.6%
Mean target
$8.91
+417.9%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.02%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.30 | $-0.32 | 0.02% |
| Dec. 31, 2025 | $-0.35 | $-0.33 | -0.02% |
| Sept. 30, 2025 | $-0.32 | $-0.34 | 0.02% |
| June 30, 2025 | $-0.33 | $-0.38 | 0.05% |
| March 31, 2025 | $-0.42 | $-0.38 | -0.04% |
| Dec. 31, 2024 | $-0.37 | $-0.46 | 0.09% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NMRA | $312M | -1.2 | — | — | -165.2% | — |
| FULC | $753M | -9.6 | 2752.0% | — | -26.6% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $176M | $201M | $143M | $92M | |
| SG&A Expense | $60M | $63M | $45M | $31M | |
| Operating Expenses | $241M | $263M | $252M | $136M | |
| Operating Income | $-241M | $-263M | $-252M | $-136M | |
| Interest Expense | $2M | · | · | · | |
| Interest Income | $8M | $20M | · | · | |
| Other Non-op | $-767.0K | $-78.0K | $-170.0K | $405.0K | |
| Pretax Income | $-237M | $-244M | $-236M | $-131M | |
| Income Tax | $130.0K | $178.0K | $268.0K | · | |
| Net Income | $-237M | $-244M | $-236M | $-131M | |
| EPS (Basic) | $-1.45 | $-1.53 | $-3.63 | $-4.81 | |
| EPS (Diluted) | $-1.45 | $-1.53 | $-3.63 | $-4.81 | |
| Shares (Basic) | 163,391,000 | 159,377,000 | 65,021,000 | 27,207,000 | |
| Shares (Diluted) | 163,391,000 | 159,377,000 | 65,021,000 | 27,207,000 | |
| EBITDA | $-241M | $-263M | $-251M | · |
Balance Sheet 22
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $183M | $142M | $374M | $241M | |
| Short-term Investments | · | $165M | $80M | $131M | |
| Prepaid Expense | $8M | $5M | $24M | $16M | |
| Current Assets | $191M | $314M | $478M | $388M | |
| PP&E (Net) | $40.0K | $1M | $2M | $2M | |
| PP&E (Gross) | $227.0K | $3M | $3M | $3M | |
| Accum. Depreciation | $187.0K | $2M | $1M | $1M | |
| Other Non-current Assets | $53.0K | $0 | · | $3M | |
| Total Assets | $191M | $317M | $496M | $426M | |
| Accounts Payable | $3M | $3M | $337.0K | $7M | |
| Accrued Liabilities | $29M | $25M | $21M | $12M | |
| Current Liabilities | $32M | $30M | $25M | $24M | |
| Capital Leases | $193.0K | $0 | $2M | $5M | |
| Total Liabilities | $87M | $30M | $27M | $29M | |
| Long-term Debt | $55M | · | · | · | |
| Total Debt | $115M | · | · | · | |
| Common Stock | $17.0K | $16.0K | $16.0K | $3.0K | |
| Retained Earnings | $-1.18B | $-947M | $-703M | $-468M | |
| AOCI | · | $62.0K | $-76.0K | $-774.0K | |
| Stockholders' Equity | $104M | $287M | $469M | $-447M | |
| Liabilities + Equity | $191M | $317M | $496M | $426M | |
| Shares Outstanding | 174,260,000 | 161,710,000 | 158,832,000 | 32,612,000 |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $208.0K | $631.0K | $668.0K | $594.0K | |
| Stock-based Comp | $30M | $40M | $17M | $8M | |
| Other Non-cash | $404.0K | $20M | $55M | · | |
| Operating Cash Flow | $-206M | $-183M | $-163M | $-115M | |
| CapEx | · | · | $117.0K | $511.0K | |
| Investing Cash Flow | $169M | $-71M | $64M | $-168M | |
| Stock Issued | · | · | $810.0K | · | |
| Net Stock Activity | · | · | $810.0K | · | |
| Financing Cash Flow | $77M | $22M | $232M | $116M | |
| Net Change in Cash | $39M | $-232M | $133M | $-167M | |
| Taxes Paid | $323.0K | $473.0K | · | · | |
| Free Cash Flow | · | · | $-163M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -93.3% | -60.0% | -51.1% | · | |
| ROE | -165.2% | -80.2% | -48.1% | · | |
| ROIC | -110.5% | -91.8% | -53.8% | · |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.9 | 10.5 | 19.0 | · | |
| Quick Ratio | 5.6 | 10.3 | 18.1 | · | |
| Debt / Equity | 1.1 | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | |
| Interest Coverage | -120.0 | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-237M | $-244M | $-236M | · | |
| Market Cap | $312M | $1.71B | $2.71B | · | |
| Enterprise Value | $244M | · | · | · | |
| P/E | -1.2 | -6.9 | -4.7 | · | |
| P/B | 3.0 | 6.0 | 5.8 | · | |
| P / Tangible Book | 3.0 | 6.0 | 5.8 | · | |
| P / Cash Flow | -1.5 | -9.4 | -16.6 | · | |
| P / FCF | · | · | -16.6 | · | |
| EV / EBITDA | -1.0 | · | · | · | |
| Earnings Yield | -81.0% | -14.4% | -21.3% | · |
Income Statement 15
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $39M | $45M | $41M | $39M | $52M | $46M | $61M | $49M | $46M | $39M | $42M | $33M | $29M | |
| SG&A Expense | $14M | $14M | $12M | $15M | $19M | $17M | $16M | $15M | $14M | $11M | $15M | $9M | $10M | |
| Operating Expenses | $53M | $58M | $58M | $54M | $71M | $63M | $77M | $64M | $60M | $114M | $57M | $42M | $39M | |
| Operating Income | $-53M | $-58M | $-58M | $-54M | $-71M | $-63M | $-77M | $-64M | $-60M | $-114M | $-57M | $-42M | $-39M | |
| Interest Expense | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $1M | $1M | $2M | · | $3M | $4M | $4M | · | · | · | · | · | · | |
| Other Non-op | $59.0K | $-269.0K | $7.0K | $-480.0K | $-25.0K | $15.0K | $-57.0K | $-24.0K | $-12.0K | $-104.0K | $-1.0K | $-39.0K | $-26.0K | |
| Pretax Income | $-53M | $-59M | $-57M | $-53M | $-68M | $-59M | $-72M | $-59M | $-54M | $-108M | $-53M | $-39M | · | |
| Income Tax | $30.0K | $0 | $0 | $25.0K | $105.0K | $0 | $53.0K | $125.0K | · | · | · | · | · | |
| Net Income | $-53M | $-59M | $-57M | $-53M | $-68M | $-59M | $-73M | $-59M | $-54M | $-109M | $-53M | $-39M | $-36M | |
| EPS (Basic) | $-0.30 | $-0.35 | $-0.35 | $-0.33 | $-0.42 | $-0.37 | $-0.45 | $-0.37 | $-0.34 | $0.01 | $-1.14 | $-1.28 | $-1.22 | |
| EPS (Diluted) | $-0.30 | $-0.35 | $-0.35 | $-0.33 | $-0.42 | $-0.37 | $-0.45 | $-0.37 | $-0.34 | $0.01 | $-1.14 | $-1.28 | $-1.22 | |
| Shares (Basic) | 179,872,000 | -321,589,000 | 161,838,000 | 161,691,000 | 161,451,000 | -317,126,000 | 159,576,000 | 158,984,000 | 157,943,000 | -41,072,000 | 46,691,000 | 30,125,000 | 29,277,000 | |
| Shares (Diluted) | 179,872,000 | -321,589,000 | 161,838,000 | 161,691,000 | 161,451,000 | -317,126,000 | 159,576,000 | 158,984,000 | 157,943,000 | -41,072,000 | 46,691,000 | 30,125,000 | 29,277,000 | |
| EBITDA | $-53M | · | $-58M | $-54M | $-71M | · | $-77M | $-64M | $-60M | · | $-57M | · | · |
Balance Sheet 22
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $147M | $183M | $129M | $125M | $127M | $142M | $276M | $151M | $183M | $374M | $412M | · | · | |
| Short-term Investments | · | · | $42M | $93M | $122M | $165M | $66M | $221M | $240M | $80M | $97M | · | · | |
| Prepaid Expense | $6M | $8M | $6M | $5M | $4M | $5M | $6M | $27M | $20M | $24M | $16M | · | · | |
| Current Assets | $153M | $191M | $177M | $223M | $255M | $314M | $349M | $398M | $443M | $478M | $526M | · | · | |
| PP&E (Net) | $32.0K | $40.0K | $80.0K | $87.0K | $982.0K | $1M | $1M | $1M | $2M | $2M | $2M | · | · | |
| PP&E (Gross) | · | $227.0K | · | · | · | $3M | · | · | · | $3M | · | · | · | |
| Accum. Depreciation | · | $187.0K | · | · | · | $2M | · | · | · | $1M | · | · | · | |
| Other Non-current Assets | $53.0K | $53.0K | $197.0K | $298.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $154M | $191M | $178M | $224M | $257M | $317M | $353M | $404M | $450M | $496M | $545M | · | · | |
| Accounts Payable | $5M | $3M | $549.0K | $644.0K | $1M | $3M | $6M | $1M | $1M | $337.0K | $2M | · | · | |
| Accrued Liabilities | $25M | $29M | $25M | $20M | $26M | $25M | $23M | $18M | $19M | $21M | $23M | · | · | |
| Current Liabilities | $30M | $32M | $26M | $21M | $28M | $30M | $32M | $23M | $25M | $25M | $29M | · | · | |
| Capital Leases | $119.0K | $193.0K | $267.0K | $339.0K | · | · | · | · | $938.0K | $2M | $3M | · | · | |
| Total Liabilities | $83M | $87M | $46M | $41M | $28M | $30M | $32M | $23M | $26M | $27M | $32M | · | · | |
| Long-term Debt | $53M | $55M | $20M | $19M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $113M | · | $40M | $39M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $17.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | · | · | |
| Retained Earnings | $-1.24B | $-1.18B | $-1.12B | $-1.07B | $-1.02B | $-947M | $-888M | $-816M | $-757M | $-703M | $-595M | · | · | |
| AOCI | · | · | $9.0K | $-15.0K | $-3.0K | $62.0K | $105.0K | $-187.0K | $-148.0K | $-76.0K | $-311.0K | · | · | |
| Stockholders' Equity | $71M | $104M | $132M | $183M | $228M | $287M | $321M | $381M | $425M | $469M | $513M | · | · | |
| Liabilities + Equity | $154M | $191M | $178M | $224M | $257M | $317M | $353M | $404M | $450M | $496M | $545M | · | · | |
| Shares Outstanding | · | 174,260,000 | · | · | · | 161,710,000 | · | · | · | 158,832,000 | · | · | · |
Cash Flow 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $9.0K | $23.0K | $19.0K | $157.0K | $157.0K | $156.0K | $160.0K | $158.0K | $166.0K | $173.0K | $171.0K | $158.0K | |
| Stock-based Comp | $7M | $7M | $6M | $7M | $9M | $10M | $10M | $13M | $7M | $6M | $6M | $3M | $2M | |
| Other Non-cash | $-359.0K | · | · | · | $-937.0K | · | · | · | $3M | · | · | · | · | |
| Operating Cash Flow | $-46M | $-48M | $-47M | $-52M | $-59M | $-50M | $-33M | $-56M | $-43M | $-51M | $-48M | $-31M | $-33M | |
| CapEx | · | · | · | · | · | · | · | · | · | $44.0K | $37.0K | $0 | $36.0K | |
| Investing Cash Flow | $71.0K | $43M | $51M | $30M | $44M | $-99M | $157M | $21M | $-150M | $14M | $24M | $24M | $3M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $11M | $59M | $-136.0K | $18M | $0 | $16M | $2M | $3M | $2M | $-481.0K | $232M | $292.0K | $101.0K | |
| Net Change in Cash | $-35M | $53M | $5M | $-4M | $-15M | $-134M | $125M | $-32M | $-191M | $-38M | $208M | $-7M | $-30M | |
| Taxes Paid | $30.0K | $323.0K | $-134.0K | $134.0K | $0 | $0 | $473.0K | · | · | · | · | · | · |
Profitability 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.0% | · | -21.4% | -16.8% | -19.2% | · | -16.2% | -29.0% | -23.9% | · | -19.5% | · | · | |
| ROE | -35.8% | · | -25.1% | -18.7% | -20.8% | · | -17.4% | -30.8% | -25.3% | · | -20.7% | · | · | |
| ROIC | -28.8% | · | -33.6% | -24.3% | -31.1% | · | -23.9% | -16.8% | · | · | · | · | · |
Liquidity & Solvency 5
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | · | 6.9 | 10.5 | 9.0 | · | 11.0 | 17.2 | 18.0 | · | 18.1 | · | · | |
| Quick Ratio | 4.9 | · | 6.6 | 10.3 | 8.8 | · | 10.8 | 16.1 | 17.2 | · | 17.5 | · | · | |
| Debt / Equity | 1.6 | · | 0.3 | 0.2 | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.7 | · | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -36.8 | · | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-231M | · | $-250M | $-252M | $-253M | · | $-238M | $-204M | $-181M | · | $-157M | · | · | |
| P/E | -1.4 | · | -1.2 | -0.5 | -0.6 | · | -5.7 | -3.1 | -3.5 | · | -3.0 | · | · | |
| Earnings Yield | -71.8% | · | -85.2% | -214.2% | -158.0% | · | -17.4% | -31.8% | -28.9% | · | -33.3% | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Net Income | $-237M | $-244M | $-236M | $-131M |
| Diluted EPS | $-1.45 | $-1.53 | $-3.63 | $-4.81 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Debt / Equity | 1.1 | — | — | — |
| Current Ratio | 5.9 | 10.5 | 19.0 | — |
| Quick Ratio | 5.6 | 10.3 | 18.1 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Free Cash Flow | — | — | $-163M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.